Ken Frazier image

Merck chief executive replaces Pfizer boss as PhRMA chairman

April 17, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing George Scangos, Ian Read, Joaquin Duato, Kenneth Frazier, PhRMA

Chairman and chief executive of Merck Kenneth Frazier is to replace Pfizer boss Ian Read as chairman at the Pharmaceutical …

alise_reicin

Merck Serono gains head of global clinical development

April 17, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alise Reicin, Merck, Merck Serono

Merck Serono, the biopharma business of Merck, has appointed Dr Alise Reicin as senior vice president and head of its …

MedImmune image

AstraZeneca signs immuno-oncology deal with UK firm

April 16, 2015
Research and Development, Sales and Marketing AstraZeneca, IMCgp100, MEDI4736, MedImmune, Oxford, immuno-oncology, immunocore, melanoma, tremelimumab

UK pharma and biotech firms AstraZeneca and Immunocore are teaming up to launch early-stage studies of potential new cancer treatments. …

Amgen image

FDA approves Amgen’s heart failure drug

April 16, 2015
Sales and Marketing Amgen, Corlanor, FDA, NICE, Vectibix, heart, ivabradine

Amgen has earned sign-off from the FDA for Corlanor as a treatment for people with worsening heart failure symptoms. Corlanor …

Abbvie image

AbbVie hep C drug gets priority review in Japan

April 16, 2015
Sales and Marketing AbbVie, EC, EU, Europe, Exviera, FDA, Japan, Viekira Pak, Viekirax, hepatitis C, ombitasvir/paritaprevir/ritonavir

AbbVie’s combination hepatitis C treatment looks set to be approved in yet another country after being granted priority review in …

Sun Pharmaceutical Industries, India

Sun Pharma and Technion form oncology research pact

April 16, 2015
Research and Development, Sales and Marketing Cancer, Sun Pharma, institute of technology, oncology, technion

Mumbai-based Sun Pharmaceuticals Industries is teaming up with the Israel Institute of Technology Technion to develop new oncology drugs. This …

julian_seward

New managing director for PM Devereux

April 16, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Julian Seward, PM Devereux

Healthcare, science and technology architectural firm PM Devereux has confirmed the appointment of Julian Seward as a managing director. Seward …

Pfizer breast cancer trial stopped following promising results

April 15, 2015
Sales and Marketing ASCO, FDA, Pfizer, ibrance, palbociclib

Regulators have stopped a Phase III clinical trial of Pfizer’s Ibrance early after it demonstrated improved survival in women with …

arzerra image

Trial results back NICE decision on Novartis cancer drug

April 15, 2015
Sales and Marketing Arzerra, Cancer, NHS, NICE, chemo, chlorambucil, fludarabine, leukaemia, ofatumumab

Treatment with Arzerra improves survival in people with chronic lymphocytic leukaemia (CLL) according to study results that back NICE’s decision …

udit_batra

Merck hires life sciences business head

April 15, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merck, Merck Millipore, Sigma-Aldrich, udit batra

Merck has confirmed that the current chief executive and president of Merck Millipore Dr Udit Batra has been appointed to lead …

astrazeneca image

FDA grants AstraZeneca immune drug orphan status

April 15, 2015
Sales and Marketing AstraZeneca, FDA, Iressa, MEDI4736, MedImmune, NSCLC, US, gefitinib, non-small cell lung cancer, tremelimumab

The US Food and Drug Administration has granted orphan drug designation to AstraZeneca’s anti-CTLA-4 monoclonal antibody tremelimumab for the treatment …

FDA image

AZ and Takeda diabetes drugs get FDA safety update

April 15, 2015
Manufacturing and Production, Sales and Marketing AstraZeneca, FDA, Nesina, Onglyza, Takeda, alogliptin, cardiovascular, diabetes, saxagliptin

An FDA advisory committee has said that the labels of two type 2 diabetes drugs should be changed to warn …

J&J image

J&J strong pharma sales can’t offset Q1 losses

April 15, 2015
Sales and Marketing J&J, JJ, Q1, Waldenström's macroglobulinemia, Waldenström’s Macroglobulinemia, Zytiga, abiraterone acetate, financials, ibrutinib, imbruvica

Johnson & Johnson’s pharma division achieved worldwide sales of $7.7 billion in the first quarter of this year – but …

oliver_albrecht_

Vetter confirms new managing director

April 15, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Oliver Albrecht, Vetter

German contract development and manufacturing organisation Vetter has appointed Oliver Albrecht as a managing director. Albrecht replaces Max Horn in …

World Health Organisation calls for full trial transparency

April 14, 2015
Research and Development, Sales and Marketing Ben Goldacre, EU, WHO, World Health Organisation, alltrials, clinical trials, sense about science, transparency

The World Health Organization has thrown its weight behind clinical trial transparency in a new statement on its position. WHO …

J&J image

IBM partners with J&J, Apple and Medtronics ‘to transform healthcare’

April 14, 2015
Sales and Marketing Apple, J&J, JJ, ibm, medtronics

IT firm IBM has teamed up with pharma giants and tech companies to expand its presence in the health and …

Astrazeneca image

AstraZeneca partners with PatientsLikeMe

April 14, 2015
Sales and Marketing AstraZeneca, Lupus, PatientsLikeMe, Roche, diabetes, oncology, respiratory disease

AstraZeneca has signed a five-year agreement with PatientsLikeMe to give the pharma firm access to the latter’s global network of …

Sanofi image

Sanofi rules out Toujeo discount in diabetes

April 14, 2015
Sales and Marketing 100 U/mL, Boehringer, Lantus, insulin glargine [rDNA origin] injection, lilly, toujeo

Sanofi has revealed that it will not discount its new insulin Toujeo more than its current blockbuster Lantus, despite lacking …

US drug spend soars to all-time high in 2014

April 14, 2015
Manufacturing and Production, Sales and Marketing Lipitor, Obama, UK Health and Social Care Information Centre, US, drug spend, prescribing

The number of prescriptions dispensed in the US rose by 13% in 2014 a new report has shown. The increase …

Manufacturing woes hit Baxter again

April 14, 2015
Manufacturing and Production, Sales and Marketing FDA, Gemünden, Pfizer, alesse, baxter, manufacturing, recall, vectura group

Baxter is voluntarily recalling several lots of intravenous solutions due to the potential presence of particulate matter.  The news has …

The Gateway to Local Adoption Series

Latest content